Conviction | Patience's Threads

There are many such from @oraunak @soicfinance @jeevanpatwa and https://t.co/208eQbYKEF #22 by @tusharbohra

My advice would be - invest time in researching how and why synthetic biology and #biotechnology be disrupting many petro derived chemicals, textiles and other materials.

Conviction | Patience
@unseenvalue

You offer me 80% cost arbitrage (discount relative to Japan/EU/US) along with low confidence / assurance on Critical Success Factors and I won't give you a single NCE/NBE to discover, develop or manufacture. Capex/opex arbitrage is too low in the disruptive-science-pecking-order! https://t.co/O2l8dK4BUv

@unseenvalue Given high capex/opex cost structures of US/Japan/EU, how will they be able to compete with Indian API companies? https://t.co/OYhC2PUZpL
— Hiren (@hiren_investing) August 11, 2021

Conviction | Patience
@unseenvalue

ACDEGTVZ 🇺🇸 and SBLSKRP2 🇮🇳 are an unequal weight "genetically modified" high 🔥🔥 global 🧬🧬 basket.

Emphasis : "unequal" weight. In a Sunday buffet - can have extra large portion of what you really enjoy eating, by ignoring other not so tasty or healthy things 🧫🧬

Sajal Kapoor
@unseenvalue

Tomorrow is 3rd Thursday of this month 🙂

Sajal Kapoor
@unseenvalue

Animal Pharma innovators are actively looking at competent, reliable API/CDMO partners.

"We predict that the sourcing, partnering, development and funding of innovation will be more transformational and significant the next five years than ever before in animal health" - #Elanco

Sajal Kapoor
@unseenvalue

Not all chemicals companies are expensive today. I’d screen those where current EV/Sales is in 3-5x range and more importantly where the capex is set to unfold that should improve ROE, ROCE and EV/Sales. It’s more about the individual business cycle leading to earnings growth …

Sajal Kapoor
@unseenvalue

My interaction with @ETNOWlive earlier today on a variety of topics - Consumption, Healthcare, IPOs to name a view.

Sajal Kapoor
@unseenvalue

FCF = Free Cash Flow (Operating Cash after adjusting for working capital - total Capex)

MCap is based on last Friday's closing.

Q :: What stocks?
A :: “Bhaiya Ji Smile ... Kamaal karte ho Pandey jee ...” 😅

Disc: invested in the 3 businesses at single digit MCap/10Y FCF 😉

Sajal Kapoor
@unseenvalue

Dumb Retail Investors to Smart Institutional investors :: for this API to FDF to CDMO to Biotechnology synthesis

धीरे धीरे से मेरी company में आना 🎵🎶
धीरे धीरे से share को उठना 🎻

......
......

तुमने wait किया है इतना जानेजाना

Sajal Kapoor
@unseenvalue

If your salary / incentives are not dependent on the next quarter earnings, just relax!

No one has any idea where the stock is going in the short term. Your paid advisors definitely haven't got any idea. They're just making it up, so you stay with them.

Key word :: quarter

Conviction | Patience
@unseenvalue

Many stock specific questions on my DM or otherwise remain unanswered. Have shared my thesis, process/framework over many months and would encourage you all to find your own process that suits your very own genome. Learn to do that hard leg-work. Put that effort. Survive. Thrive.

[Free CDMO Masterclass #18] https://t.co/208eQbYKEF

[Free Art of Investing] https://t.co/bHvUqnpiTE

[Paid IIC Dec 2020 on SeQuent] https://t.co/3iDO438Et9

[Charity fund raise on Unseen Trends in Biotechnology] https://t.co/eNi1x1qwhH

[Q&A on APIs] https://t.co/EQGz007a9S
— Conviction | Patience (@unseenvalue) July 25, 2021

Sajal Kapoor
@unseenvalue

Attended #Rallis AGM last week. Not seen a better AGM in the Chemicals sector. Went for nearly 3 hrs and Mr Bhaskar Bhat (Chairman) and Mr Sanjiv Lal (CEO) answered every question raised in detail.

Extract from Annual Report of #RallisIndia

Emphasis on Biotechnology in Crop Nutrition & Seeds business

Capex Plans \u20b9800 Cr next 5 yrs. \u20b9200 Cr approx in FY22, largely be funded from internal accrual

Thanks to @unseenvalue @ishmohit1 for their Webinar on Biotechnology

(1/2) pic.twitter.com/CCAS72KlN2
— Soumen Chatterjee (@Aries_Martian) June 27, 2021

Conviction | Patience
@unseenvalue

@connectgurmeet Real estate - unseen exposure

Playing real estate and home improvement structural story in \U0001f1ee\U0001f1f3 via a focused proxy consumption \U0001f9fa

1. Asian Paints
2. Pidilite
3. SHIL (Hindware portfolio)
4. Fragrance SpecChem (Kelkar & Fairchem)

Consumption | Proxy Consumption
— Conviction | Patience (@unseenvalue) January 10, 2020

Sajal Kapoor
@unseenvalue

Domestic pharma's Acute was disrupted in FY21 due to Covid and most businesses are sitting on a low FY21 base. They can grow handsomely not only this fiscal, but also medium to long term. If a debt-free businesses can do 20-25% ROCE despite Covid, what can be the FY23e EV/Sales?

Sajal Kapoor
@unseenvalue

Context ::

https://t.co/jKwBEs81CB

Listen from around 2:21:00

#CDMO

Conviction | Patience
@unseenvalue

@oldschoolinvest I said 20-25% #CDMO (Synthesis) growth going forward in @IIC_Conference June 2020 conclave. They have delivered better than my expectations.

Never Knowingly Misguide.

Money making and fake advisory/PMS propaganda has never been my agenda

In just 15 years, #LaurusLabs has scaled up like no other..!

Numbers v Narrative: Well balanced 2800 Cr sales + huge competitive advantage in terms of IP/patents/synthesis capability!

Comparing Laurus with others - 1 hrs 28 mins\U0001f447https://t.co/Zzx6AwHZLH

Conviction | Patience pic.twitter.com/I6bImfjDCW
— Conviction | Patience (@unseenvalue) July 5, 2020

Sajal Kapoor
@unseenvalue

@harindersnanda @FortuneIndia https://t.co/64WUswITen

Listen to this one (timestamp 2:35)
#KRAS mutation

Sajal Kapoor
@unseenvalue

Bolo Jaikara Bicara 🇮🇳🇺🇸

#Bicara presented clinical data from the lead immunotherapy program, BCA101, at ASCO 2021 - June 2021

Title: First-in-human phase I study of the bifunctional EGFR/TGF\u03b2 fusion protein BCA101 in patients with EGFR-driven advanced solid cancers

Unseen Bicara Pipeline\U0001f9ec https://t.co/bMhtUEnw0C pic.twitter.com/cz6V5BLeuc
— Punit (@punitbansal14) June 17, 2021

Conviction | Patience
@unseenvalue

Barsaat ke mausam main ...
Tanhai ke aalam main ...
🎼🌈
Abhi zinda hoon to jee leney jee leney do ...
Bhari barsaat main Tata Chai pee leney do ... @connectgurmeet

Invested from lower levels. Not for trading. No reco.

Sajal Kapoor
@unseenvalue

Most stocks are fit for short term trading. Not every business will compound wealth over the long term. Some commonly used proxies for long term compounding 'potential' (in alphabetic order) ::

Cash flow per share
Earnings per share
Scientists per share
Tweets per share

SAnngeri Authors Conviction | Patience